상세 보기
Durable Clinical Benefit of B-Cell Maturation Antigen-Directed Therapy With Belantamab Mafodotin Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: DREAMM-8 Long-Term Responder Analysis
- Dimopoulos, Meletios A.;
- Beksac, Meral;
- Delimpasi, Sosana;
- Vorobyev, Vladimir;
- Quach, Hang;
- ... Kim, Kihyun;
- 외 13명
Citations
WEB OF SCIENCE
0키워드
MM; DREAMM-8; B-cell maturation antigen; antibody-drug conjugate; subgroup analysis; phase 3
- 제목
- Durable Clinical Benefit of B-Cell Maturation Antigen-Directed Therapy With Belantamab Mafodotin Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: DREAMM-8 Long-Term Responder Analysis
- 저자
- Dimopoulos, Meletios A.; Beksac, Meral; Delimpasi, Sosana; Vorobyev, Vladimir; Quach, Hang; Spic, Ivan; Radocha, Jakub; Robak, Pawel; Kim, Kihyun; Cavo, Michele; Zafar, Syed; Moore, Ainslee; Morris, Kristin; Polinkovsky, Margaret; Brock, Kelly; Grams, Joanna; Manasanch, Elisabet; Mateos, Maria-Victoria; Trudel, Suzanne
- 발행일
- 2026-08
- 유형
- Meeting Abstract
- 권
- 26
- 페이지
- S1058 ~ S1059
- 언어
- ENG
- 출판사
- ELSEVIER SCIENCE INC
- 발행국가
- 미국
- ISSN
- E 2152-2669
P 2152-2650